Navigation Links
Cambrex Reports First Quarter of 2011 Results
Date:5/5/2011

antly higher year over year.  In addition to the increases in sales volumes for some of our larger custom manufacturing products, we continue to see strong orders for our generic APIs.  Cambrex Zenara is off to a positive start and has been asked to increase production as part of their customer's launch of a leading nicotine replacement therapy product in India."

Guidance – Continuing OperationsThe Company continues to expect that sales for 2011, excluding the impact of foreign currency, will increase between 3% and 7% versus 2010, and that full year 2011 EBITDA will be between $43 and $49 million.  EBITDA guidance is for continuing operations and excludes the impact of any M&A or restructuring activities.  The above guidance does not reflect Cambrex Zenara, which is accounted for using the equity method, and as such is not consolidated into the Company's results.  Cambrex's income statement reflects 51% of Cambrex Zenara's net results as Equity in Losses of Partially-Owned Affiliate.  For 2011, Cambrex Zenara is expected to have revenues in the low to mid single digit millions and a small EBITDA loss.

Capital expenditures are expected to be approximately $14 to $17 million and depreciation is expected to be $21 to $23 million in 2011.

The financial information contained in this press release is unaudited, subject to revision and should not be considered final until the Company's first quarter 2011 Form 10-Q is filed with the SEC.

Conference Call and WebcastThe Conference Call to discuss first quarter of 2011 results will begin at 8:30 a.m. Eastern Time on Friday, May 6, 2011 and last approximately 45 minutes.  Those wishing to participate should call 1-888-299-7230 for domestic and +1-719-325-2168 for international.  Please use the pass code 7839366 and call approximately 10 minutes prior to start time.  A webcast is available from the Investors section on the Cam
'/>"/>

SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cambrex Reports Fourth Quarter and Full Year 2010 Results
2. Cambrex to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
3. Cambrex Zenara Manufacturing Facility Receives European GMP Approval
4. Shawn P. Cavanagh Appointed Chief Operating Officer of Cambrex
5. Cambrex Zenara Supplies Product for Launch of Nicorette® in India
6. Cambrex Acquires Stake in Zenara Pharma
7. Cambrex to Announce Third Quarter 2010 Financial Results on November 3, 2010
8. Cambrex Acquires IEP GmbH
9. Cambrex Reports Third Quarter 2009 Results
10. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
11. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... community to review the clinical development strategy for ... on Friday, May 8, 2015. Topics will include ... planned clinical activities for AST-OPC1. ...
(Date:5/6/2015)... INCLINE VILLAGE, Nev., May 6, 2015 PDL BioPharma, ... results for the first quarter ended March 31, 2015. ... 2015 increased nine percent to $149.7 million from $136.8 ... the quarter ended March 31, 2015 included $127.8 million ... the Queen et al. patents, $11.4 million in net ...
(Date:5/6/2015)... 6, 2015 Lannett Company, Inc. (NYSE: ... 2015 third quarter ended March 31, 2015.  ... rose 24% to $99.4 million from $80.0 million in ... $75.6 million, or 76% of net sales, from $56.1 ... (R&D) expenses decreased to $9.2 million from $10.6 million ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8
... Schein, Inc. (Nasdaq: HSIC ), the largest provider ... today that it will release its third quarter 2010 financial ... 2010, and will provide a live webcast of its earnings ... Eastern Daylight Time. Speakers on the call will include Stanley ...
... PITTSBURGH, Oct. 15 Mylan Inc. (Nasdaq: ... Inc. received final approvals from the U.S. Food and ... (ANDAs) for the generic versions of Hyzaar® Tablets, 50 ... 25 mg, 50 mg and 100 mg, both antihypertensives. ...
Cached Medicine Technology:Henry Schein to Webcast Third Quarter 2010 Conference Call Friday, October 29, at 10:00 a.m. EDT 2Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar® 2
(Date:5/6/2015)... May 06, 2015 Corporate Executives ... of MEBC, an Alliance Award for excellence in ... FOCUS 2015, JDA’s annual user conference which brought ... and wholesale distribution sectors. This award recognizes MEBC, ... receiving services that advance their supply chain performance ...
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... Waltham, MA (PRWEB) May 06, 2015 ... information for healthcare professionals and students, announced today that ... UpToDate®, 94% confirmed that use of the clinical decision ... Additionally, by the end of 2014, UpToDate users in ... million clinical topics per month, on average. In Germany ...
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive ... it to the headlines of major publications world-wide. With ... and Hyundai ready to share their visions for the ... way for press to go behind the scenes and ... TU-Automotive said “This year we’re releasing a preview of ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2
... LUGANO, Switzerland, September 9 As part of the ... as new,CEO in the American subsidiary, Helsinn Therapeutics (U.S.) ... the recently acquired,Helsinn Therapeutics, and has held leadership positions ... in Research. , Moreover, Helsinn ...
... ... with medically inoperable lung cancer. , ... Phoenix, Arizona (Vocus) September 9, 2009 -- Today, DoctorFinders.com ( http://doctorfinders.com/ ... medically inoperable lung cancer ., , , , ,Medically inoperable cancer can be ...
... ... Cosmetic Dentistry, well known for dental care as well as cosmetic and sedation dentistry, ... ... 9, 2009 -- Raleigh Comprehensive and Cosmetic Dentistry, led by Dr. Robert L. Williamson ...
... , - Choosing a More Appropriate ... to Improvement , The first results of ... presented today at the 6th congress,of the European Federation of Chapters ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090909/358726 ) , ...
... light, 300 million metres per second, was long thought ... matter and energy but recent research in the area ... manipulate light to some ingenious and hugely lucrative ends. ... perfect images of distant galaxies or detailed representations inside ...
... infectious bacteria in an experimental system, researchers at University ... in the body the bacteria go giving an ... to the development of more targeted treatments. At ... Edinburgh, Dr Cormac Gahan described how his research team ...
Cached Medicine News:Health News:New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc. 2Health News:CyberKnife Treatment for Medically Inoperable Lung Cancer 2Health News:Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family 2Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 2Health News:First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 3Health News:Light at the speed of a bicycle and much more 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: